A Double-Blind, Randomised, Crossover Trial of Two Botulinum Toxin Type A in Patients with Spasticity

BACKGROUND: Botulinum toxin type A (btxA) is one of the main treatment choices for patients with spasticity. Prosigne® a new released botulinum toxin serotype A may have the same effectiveness as Botox® in focal dystonia. However, there are no randomized clinical trials comparing these formulations...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Guarany, Fábio Coelho, Picon, Paulo Dornelles, Guarany, Nicole Ruas, dos Santos, Antonio Cardoso, Chiella, Bianca Paula Mentz, Barone, Carolina Rocha, Fendt, Lúcia Costa Cabral, Schestatsky, Pedro
Format: Artigo
Sprache:Inglês
Veröffentlicht: Public Library of Science 2013
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3585303/
https://ncbi.nlm.nih.gov/pubmed/23468866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0056479
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge